{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:34:48Z","timestamp":1787009688828,"version":"build-2736575974"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute bacterial meningitis remains a major cause of mortality and morbidity, especially in lower-income countries. Thus, in 2017, a group of people concerned with this continuing problem came together to plan a way forward. A task force was established, a baseline situation analysis undertaken and a road map for a new initiative \u2018Defeating Meningitis by 2030\u2019 prepared. This road map will be launched officially in September 2021. Additional finances for meningitis control will be needed, together with the support of many different institutions and people with different skills, if the \u2018Defeating Meningitis by 2030\u2019 initiative is to achieve its ambitious goals.<\/jats:p>","DOI":"10.1093\/trstmh\/trab133","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T15:18:22Z","timestamp":1629127102000},"page":"1099-1101","source":"Crossref","is-referenced-by-count":17,"title":["Defeating meningitis by 2030 \u2013 an ambitious target"],"prefix":"10.1093","volume":"115","author":[{"given":"Brian","family":"Greenwood","sequence":"first","affiliation":[{"name":"Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St., London WC1E\u00a07HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samba","family":"Sow","sequence":"additional","affiliation":[{"name":"Centre for Vaccine Development, Avenue Mohamed VI, Djikoni, 251, Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Preziosi","sequence":"additional","affiliation":[{"name":"Department of Immunization, Vaccines and Biologicals, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"issue":"2","key":"2021100202532049900_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/microorganisms9020377","article-title":"The global burden of meningitis in children: challenges with interpreting global health estimates","volume":"9","author":"Wright","year":"2021","journal-title":"Microorganisms"},{"key":"2021100202532049900_bib2","volume-title":"GBD Results Tool","author":"Institute for Health Metrics and Evaluation","year":"2021"},{"issue":"5","key":"2021100202532049900_bib3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/microorganisms9050900","article-title":"The impact and burden of neurological sequelae following bacterial meningitis; a narrative review","volume":"9","author":"Schiess","year":"2021","journal-title":"Microorganisms"},{"issue":"12","key":"2021100202532049900_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/14760584.2018.1547637","article-title":"Meningococcal B vaccine (4CMenB); the journey from research to real world experience","volume":"17","author":"Rappuoli","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"2021100202532049900_bib5","first-page":"2669","article-title":"Progress toward a group B streptococcal vaccine","volume":"14","author":"Song","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2021100202532049900_bib6","author":"World Health Organization","year":"2021"},{"key":"2021100202532049900_bib7","volume-title":"Defeating meningitis by 2030: a global road map","author":"World Health Organization","year":"2021"},{"key":"2021100202532049900_bib8","author":"World Health Assembly","year":"2021"},{"issue":"2","key":"2021100202532049900_bib9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/21645515.2020.1804776","article-title":"Vaccines and routine immunization strategies during the COVID-19 pandemic","volume":"17","author":"Dinleyici","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"2021100202532049900_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","article-title":"Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap","volume":"51","author":"Cohen","year":"2021","journal-title":"Infect Dis Now"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/115\/10\/1099\/40499099\/trab133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/115\/10\/1099\/40499099\/trab133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T22:55:08Z","timestamp":1633128908000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/115\/10\/1099\/6363519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,9,2]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trab133","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10]]},"published":{"date-parts":[[2021,9,2]]}}}